Ipsen

This study is testing whether a new injection called IPN10200 works better than a placebo for adults with cervical dystonia, a condition that causes painful neck muscle spasms and abnormal head positions. The current standard treatment involves injections that wear off after abou…

This study is testing whether injections of an experimental drug called IPN10200 can help prevent migraine attacks in adults. The drug works by blocking chemical messengers in the brain that cause migraine pain. Researchers will give 641 participants with either episodic or chron…

This is the first time a new drug called IPN01195 is being tested in people. The study aims to find a safe and effective dose for adults with advanced solid tumors that have spread and have specific genetic changes. Researchers will test different doses to see how the body handle…

This study is testing if a daily pill called elafibranor can slow down the worsening of primary biliary cholangitis (PBC), a serious liver disease that can lead to liver failure, transplant, or death. It will compare the drug to a placebo in about 276 adults who already have live…

This study is observing how well the cancer drug cabozantinib works and how safe it is for adults with advanced neuroendocrine tumors (NETs) who have already tried at least one other treatment. It will follow about 150 patients in Germany and Austria who are already receiving thi…

This study will follow about 424 people with Primary Biliary Cholangitis (PBC), a rare and progressive liver disease, for five years as they take the drug elafibranor in real-world settings. The main goal is to see how well the drug works to control the disease, how safe it is, a…

This study is testing a new oral drug called IPN01194 in adults with advanced solid tumors that have spread and have specific genetic changes. The main goals are to find a safe and tolerable dose and to see if the drug can help shrink tumors. The study is open to people with cert…

This study is testing a new cancer drug called IPN01203 in adults with advanced solid tumors that have spread and stopped responding to standard immunotherapies. Researchers will first find the safest and most effective dose, then test how well the drug controls tumor growth. The…

This early-stage study is testing a new drug called IPN60300 in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. All participants will receive the dru…

This study follows 30 patients with Alagille syndrome (ALGS), a rare genetic disease that damages the liver, as they take the medication odevixibat (Bylvay) in their daily lives. The main goal is to see how well the drug works and how safe it is over the long term. Researchers wi…

This study is collecting long-term information from about 10 people in South Korea who are already taking odevixibat (Bylvay) for a rare liver disease called PFIC. The goal is to see how well the medicine works and how safe it is over many years in everyday life. It will track he…

This study aims to collect long-term safety and effectiveness information on the drug palovarotene for people with Fibrodysplasia Ossificans Progressiva (FOP), a rare disease that causes bone to grow in muscles and soft tissues. It will follow about 100 people, both children and …

This study is testing a single injection called IPN10200 to see if it safely improves the appearance of moderate to severe frown lines between the eyebrows. About 300 adults will receive either the real injection or a placebo (a dummy treatment with no active drug). Researchers w…

This study is testing a new injection called IPN10200 to reduce muscle stiffness in the arms of adults who have had a stroke or traumatic brain injury. Researchers will give different doses to 240 participants to find which works best with the fewest side effects. The goal is to …

This study is testing a new injectable treatment called IPN10200 for reducing the appearance of moderate to severe forehead lines, frown lines, and crow's feet. Researchers want to find the safest and most effective dose by comparing it to a placebo and an existing treatment. The…

This study is testing a new injectable treatment called IPN10200 for reducing moderate to severe frown lines between the eyebrows. It will involve about 1300 adults to see if a single treatment is effective and safe compared to a placebo, and to learn how well and safely repeat t…

This study aims to understand how often specific inherited genetic changes are present in Spanish adults with unexplained, recurring liver problems related to bile flow. Researchers will enroll 150 adults for a single visit to collect health information and a blood sample for gen…

This study aims to learn about the safety of the drug odevixibat during pregnancy and breastfeeding. It will observe about 20 people who took the drug while pregnant or nursing, collecting information from their regular medical records. The goal is to see if the drug is linked to…

This study aims to understand how common painful muscle stiffness (spasticity) is in the year after a person's first stroke. It will follow over 1,000 stroke survivors to see how many develop this condition and when it typically starts. The goal is to create a standard, better wa…